NAMSA, a Northwood, Ohio-based medical device research organization, recently announced the opening of its newest office located near Frankfurt, Germany.

The new office is staffed to provide clinical research and consulting services throughout Europe and will serve clients seeking regulatory approval to market medical devices in the European Union, in addition to providing regulatory and clinical trial support to European companies seeking clearance from the U.S. Food and Drug Administration.

European market approval has emerged as a preferred pathway for medical device manufacturers primarily due to more efficient approval processes.

"The placement of this office reinforces NAMSA's commitment to helping our clients design and execute regulatory strategies, develop new therapies and launch them in the most efficient manner possible," said John Gorski, president and CEO.

NAMSA's testing laboratory in Lyon, France, has provided non-clinical safety and efficacy studies to medical device companies since 1986.

"The combination of non-clinical and clinical research expertise at our European locations enables NAMSA to provide our clients with a higher level of continuity, consistency and convenience throughout the product development process," Gorski added.